This is because the ubiquitin-specific peptidase 48 (USP48) in hepatoma cells can combine with SIRT6, a histone deacetylase, to improve the stability of SIRT6, which plays a role in weakening the glycolysis of hepatoma cells. Here, SIRT6 is linked to hepatocellular carcinoma.